本发明涉及一种抗动脉粥样血栓形成剂与抗血小板凝集剂的新组合产品。
The invention relates to a novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent.
具有降低脑血管阻力，改善脑血循环、增加脑血流量及抗血小板凝集的作用。
It can reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has anti-platelet aggregation effect.
作用：具有降低脑血管阻力，改善脑学循环、增加脑学流量及抗血小板凝集的作用。
Function: It can reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has an anti-plate aggregation effect.
茶多酚还具有抗血凝、促纤溶和抑制血小板凝集作用，对动脉粥样硬化的预防具有积极意义。
It also can prevent blood from coagulating, promote the dissolution of fibre and inhibit the agglutination of blood platelet, and play active role of preventing atherosclerosis.
茶多酚还具有抗血凝、促纤溶和抑制血小板凝集作用，对动脉粥样硬化的预防具有积极意义。
It also can prevent blood from coagulating, promote the dissolution of fibre and inhibit the agglutination of blood platelet, and play active role of preventing atherosclerosis.
应用推荐